Anthony Francis Massaro, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuromuscular Blocking Agents | 3 | 2023 | 132 | 0.570 |
Why?
|
| Intensive Care Units | 10 | 2024 | 3804 | 0.540 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2016 | 280 | 0.420 |
Why?
|
| Respiration, Artificial | 6 | 2023 | 2723 | 0.370 |
Why?
|
| Length of Stay | 5 | 2019 | 6521 | 0.350 |
Why?
|
| Nitric Oxide | 8 | 2002 | 2146 | 0.330 |
Why?
|
| Infection Control | 1 | 2016 | 985 | 0.320 |
Why?
|
| Respiration | 5 | 2016 | 1667 | 0.290 |
Why?
|
| Communication | 6 | 2017 | 3910 | 0.260 |
Why?
|
| Referral and Consultation | 1 | 2018 | 3629 | 0.250 |
Why?
|
| Patient Participation | 4 | 2017 | 1450 | 0.220 |
Why?
|
| Sepsis | 4 | 2018 | 2602 | 0.200 |
Why?
|
| Hospital Mortality | 5 | 2019 | 5371 | 0.200 |
Why?
|
| Patient Care Planning | 5 | 2017 | 904 | 0.190 |
Why?
|
| Professional-Family Relations | 2 | 2017 | 501 | 0.190 |
Why?
|
| Neuromuscular Blockade | 1 | 2022 | 148 | 0.180 |
Why?
|
| Patient Care Team | 5 | 2017 | 2526 | 0.170 |
Why?
|
| Quality Indicators, Health Care | 3 | 2018 | 1813 | 0.170 |
Why?
|
| Critical Care | 5 | 2023 | 2717 | 0.160 |
Why?
|
| Asthma | 7 | 2021 | 6274 | 0.160 |
Why?
|
| Behavior | 1 | 2021 | 545 | 0.150 |
Why?
|
| Mental Disorders | 1 | 2018 | 6879 | 0.150 |
Why?
|
| Hydroxychloroquine | 1 | 2020 | 427 | 0.130 |
Why?
|
| Thorax | 1 | 2019 | 559 | 0.130 |
Why?
|
| Patient Preference | 2 | 2017 | 948 | 0.130 |
Why?
|
| Anesthetics | 1 | 2022 | 525 | 0.130 |
Why?
|
| Respiratory Therapy | 1 | 2016 | 125 | 0.130 |
Why?
|
| Oral Hygiene | 1 | 2016 | 132 | 0.130 |
Why?
|
| Critical Illness | 2 | 2019 | 2754 | 0.120 |
Why?
|
| Blood Circulation | 1 | 1996 | 248 | 0.120 |
Why?
|
| Environment | 1 | 2021 | 1126 | 0.120 |
Why?
|
| Chlorhexidine | 1 | 2016 | 160 | 0.120 |
Why?
|
| Ulcer | 1 | 2016 | 204 | 0.120 |
Why?
|
| Patient-Centered Care | 3 | 2024 | 1439 | 0.120 |
Why?
|
| Metabolomics | 2 | 2014 | 1675 | 0.120 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2016 | 248 | 0.110 |
Why?
|
| Patient Positioning | 1 | 2016 | 332 | 0.110 |
Why?
|
| Computers, Handheld | 1 | 2015 | 211 | 0.110 |
Why?
|
| Respiratory Insufficiency | 2 | 2020 | 1244 | 0.110 |
Why?
|
| Long-Term Care | 1 | 2017 | 633 | 0.100 |
Why?
|
| Systemic Inflammatory Response Syndrome | 2 | 2016 | 620 | 0.100 |
Why?
|
| Critical Pathways | 1 | 2016 | 476 | 0.100 |
Why?
|
| Bronchi | 1 | 1996 | 847 | 0.100 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2016 | 640 | 0.090 |
Why?
|
| Life Support Systems | 1 | 2010 | 11 | 0.090 |
Why?
|
| Physician-Patient Relations | 2 | 2010 | 3267 | 0.090 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 2 | 1990 | 897 | 0.090 |
Why?
|
| User-Computer Interface | 1 | 2017 | 1398 | 0.090 |
Why?
|
| Anesthesia | 1 | 2022 | 1596 | 0.090 |
Why?
|
| Breath Tests | 2 | 2002 | 300 | 0.090 |
Why?
|
| Hypoxia, Brain | 1 | 2010 | 139 | 0.090 |
Why?
|
| Circadian Rhythm | 1 | 2021 | 2585 | 0.080 |
Why?
|
| Thromboembolism | 1 | 2016 | 1005 | 0.080 |
Why?
|
| Cross Infection | 1 | 2018 | 1425 | 0.080 |
Why?
|
| Family | 2 | 2017 | 3208 | 0.080 |
Why?
|
| Inpatients | 2 | 2017 | 2561 | 0.080 |
Why?
|
| Hypnotics and Sedatives | 1 | 2016 | 1188 | 0.080 |
Why?
|
| DNA, Mitochondrial | 1 | 2013 | 871 | 0.080 |
Why?
|
| Acute Lung Injury | 1 | 2012 | 378 | 0.080 |
Why?
|
| Guideline Adherence | 1 | 2018 | 2239 | 0.070 |
Why?
|
| Male | 28 | 2024 | 364761 | 0.070 |
Why?
|
| Internet | 2 | 2017 | 3123 | 0.070 |
Why?
|
| Bacteremia | 1 | 2014 | 985 | 0.070 |
Why?
|
| Caregivers | 2 | 2017 | 2302 | 0.070 |
Why?
|
| Emergency Service, Hospital | 2 | 2024 | 7955 | 0.070 |
Why?
|
| Quality Improvement | 3 | 2017 | 3858 | 0.070 |
Why?
|
| Inflammasomes | 1 | 2012 | 541 | 0.070 |
Why?
|
| Humans | 42 | 2024 | 768369 | 0.070 |
Why?
|
| Delirium | 1 | 2018 | 1694 | 0.070 |
Why?
|
| Middle Aged | 16 | 2020 | 223406 | 0.070 |
Why?
|
| Female | 29 | 2021 | 396926 | 0.070 |
Why?
|
| Glucocorticoids | 1 | 1995 | 2170 | 0.060 |
Why?
|
| Cohort Studies | 6 | 2018 | 41782 | 0.060 |
Why?
|
| Sleep | 1 | 2021 | 4796 | 0.060 |
Why?
|
| Hypothermia, Induced | 1 | 2010 | 756 | 0.060 |
Why?
|
| Neoplasms, Experimental | 1 | 1990 | 1232 | 0.060 |
Why?
|
| Massachusetts | 2 | 2016 | 8905 | 0.060 |
Why?
|
| Interviews as Topic | 3 | 2017 | 2733 | 0.060 |
Why?
|
| Physicians | 1 | 2022 | 4615 | 0.060 |
Why?
|
| Electronic Health Records | 2 | 2022 | 4877 | 0.060 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 1990 | 2564 | 0.060 |
Why?
|
| Aged | 16 | 2022 | 171514 | 0.060 |
Why?
|
| Interleukin-2 | 5 | 1990 | 1892 | 0.050 |
Why?
|
| Health Personnel | 1 | 2017 | 3384 | 0.050 |
Why?
|
| Lymphocyte Activation | 3 | 1990 | 5490 | 0.050 |
Why?
|
| Monitoring, Physiologic | 1 | 2010 | 1795 | 0.050 |
Why?
|
| Hospitalization | 3 | 2022 | 10845 | 0.050 |
Why?
|
| Forced Expiratory Volume | 3 | 1998 | 1820 | 0.050 |
Why?
|
| APACHE | 2 | 2019 | 268 | 0.050 |
Why?
|
| Quality of Health Care | 1 | 2017 | 4340 | 0.050 |
Why?
|
| Bronchial Provocation Tests | 2 | 2000 | 216 | 0.050 |
Why?
|
| Models, Theoretical | 1 | 2013 | 3590 | 0.050 |
Why?
|
| Adult | 17 | 2023 | 223528 | 0.050 |
Why?
|
| Paralysis | 1 | 2022 | 250 | 0.050 |
Why?
|
| Prospective Studies | 6 | 2018 | 54913 | 0.050 |
Why?
|
| Leukotriene E4 | 1 | 2000 | 75 | 0.050 |
Why?
|
| Heart Arrest | 1 | 2010 | 1516 | 0.040 |
Why?
|
| Methacholine Chloride | 1 | 2000 | 220 | 0.040 |
Why?
|
| Pharmacists | 1 | 2023 | 261 | 0.040 |
Why?
|
| Early Diagnosis | 2 | 2016 | 1196 | 0.040 |
Why?
|
| Palliative Care | 3 | 2024 | 3644 | 0.040 |
Why?
|
| Cooperative Behavior | 2 | 2017 | 1514 | 0.040 |
Why?
|
| Severity of Illness Index | 5 | 2020 | 15965 | 0.040 |
Why?
|
| Pulmonary Circulation | 1 | 2002 | 744 | 0.040 |
Why?
|
| Proteomics | 1 | 2013 | 3901 | 0.040 |
Why?
|
| Exercise | 1 | 1996 | 5940 | 0.040 |
Why?
|
| Bronchodilator Agents | 1 | 2002 | 519 | 0.040 |
Why?
|
| Terminal Care | 1 | 2010 | 1773 | 0.040 |
Why?
|
| Spirometry | 2 | 2000 | 928 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2024 | 8730 | 0.040 |
Why?
|
| Decision Making | 2 | 2024 | 3961 | 0.040 |
Why?
|
| Cytokines | 1 | 2012 | 7440 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2020 | 81835 | 0.030 |
Why?
|
| Medical Audit | 1 | 2018 | 454 | 0.030 |
Why?
|
| Tracheotomy | 1 | 2017 | 168 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 1990 | 9261 | 0.030 |
Why?
|
| Bronchoscopes | 1 | 1996 | 64 | 0.030 |
Why?
|
| Qualitative Research | 2 | 2017 | 3115 | 0.030 |
Why?
|
| Beclomethasone | 1 | 1995 | 38 | 0.030 |
Why?
|
| Air | 1 | 1996 | 187 | 0.030 |
Why?
|
| Peak Expiratory Flow Rate | 1 | 1995 | 144 | 0.030 |
Why?
|
| Triamcinolone | 1 | 1995 | 68 | 0.030 |
Why?
|
| Quality of Life | 1 | 2017 | 13497 | 0.030 |
Why?
|
| Organizational Objectives | 1 | 2017 | 427 | 0.030 |
Why?
|
| Computer Security | 1 | 2017 | 260 | 0.030 |
Why?
|
| Inservice Training | 1 | 2017 | 377 | 0.030 |
Why?
|
| Nursing Informatics | 1 | 2014 | 46 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2020 | 2655 | 0.030 |
Why?
|
| Organ Size | 1 | 2019 | 2268 | 0.030 |
Why?
|
| Fiber Optic Technology | 1 | 1996 | 291 | 0.030 |
Why?
|
| Hospitals | 2 | 2018 | 3906 | 0.030 |
Why?
|
| Airway Obstruction | 2 | 1998 | 672 | 0.030 |
Why?
|
| Access to Information | 1 | 2017 | 317 | 0.030 |
Why?
|
| Methylprednisolone | 1 | 1995 | 387 | 0.030 |
Why?
|
| Organizational Culture | 1 | 2017 | 510 | 0.030 |
Why?
|
| Disinfection | 1 | 2015 | 207 | 0.030 |
Why?
|
| Pulmonary Alveoli | 1 | 1996 | 666 | 0.030 |
Why?
|
| Macaca | 1 | 2014 | 417 | 0.030 |
Why?
|
| Nasopharynx | 1 | 1996 | 420 | 0.030 |
Why?
|
| Pandemics | 2 | 2023 | 8751 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2020 | 59679 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 1990 | 10269 | 0.030 |
Why?
|
| Lung | 2 | 2019 | 10090 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2002 | 4202 | 0.020 |
Why?
|
| Professional-Patient Relations | 1 | 2017 | 727 | 0.020 |
Why?
|
| Caspase 1 | 1 | 2012 | 227 | 0.020 |
Why?
|
| United States | 4 | 2018 | 73120 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2017 | 997 | 0.020 |
Why?
|
| Focus Groups | 1 | 2017 | 1448 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2021 | 22286 | 0.020 |
Why?
|
| Prednisone | 1 | 1995 | 1568 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2020 | 3234 | 0.020 |
Why?
|
| Interleukin-18 | 1 | 2012 | 251 | 0.020 |
Why?
|
| Checklist | 1 | 2017 | 843 | 0.020 |
Why?
|
| Trachea | 1 | 1996 | 1095 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2012 | 762 | 0.020 |
Why?
|
| Killer Cells, Lymphokine-Activated | 1 | 1989 | 42 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 1990 | 1352 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2012 | 752 | 0.020 |
Why?
|
| Emergencies | 1 | 1995 | 1222 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2020 | 3854 | 0.020 |
Why?
|
| Vital Capacity | 2 | 2002 | 984 | 0.020 |
Why?
|
| Medical Informatics | 1 | 2015 | 737 | 0.020 |
Why?
|
| Intubation, Intratracheal | 1 | 1996 | 1359 | 0.020 |
Why?
|
| Quality Assurance, Health Care | 1 | 2018 | 2179 | 0.020 |
Why?
|
| Disease Management | 1 | 2018 | 2533 | 0.020 |
Why?
|
| Ibuprofen | 1 | 1989 | 229 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 10358 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 2 | 2018 | 7449 | 0.020 |
Why?
|
| Cancer Care Facilities | 1 | 2010 | 424 | 0.020 |
Why?
|
| Hospices | 1 | 2010 | 245 | 0.020 |
Why?
|
| Neoplasms | 4 | 2010 | 22389 | 0.020 |
Why?
|
| Time Factors | 3 | 2018 | 40271 | 0.020 |
Why?
|
| Adaptive Immunity | 1 | 2012 | 734 | 0.020 |
Why?
|
| Coma | 1 | 2010 | 488 | 0.020 |
Why?
|
| Point-of-Care Systems | 1 | 2015 | 1227 | 0.020 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2016 | 1176 | 0.020 |
Why?
|
| Evidence-Based Practice | 1 | 2010 | 500 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 1988 | 621 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2010 | 937 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 2010 | 1444 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 3484 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 12096 | 0.010 |
Why?
|
| Acute Disease | 1 | 1995 | 7245 | 0.010 |
Why?
|
| Oxygen | 1 | 1996 | 4269 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2003 | 39429 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 18390 | 0.010 |
Why?
|
| Life Expectancy | 1 | 2010 | 1249 | 0.010 |
Why?
|
| Inflammation | 2 | 2020 | 10863 | 0.010 |
Why?
|
| Adjuvants, Immunologic | 1 | 1989 | 998 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2017 | 7863 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2017 | 3922 | 0.010 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2010 | 997 | 0.010 |
Why?
|
| Forced Expiratory Flow Rates | 1 | 2002 | 75 | 0.010 |
Why?
|
| Killer Cells, Natural | 2 | 1989 | 2207 | 0.010 |
Why?
|
| Anxiety | 1 | 2017 | 4655 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2017 | 9379 | 0.010 |
Why?
|
| Immunotherapy, Adoptive | 1 | 1992 | 1505 | 0.010 |
Why?
|
| Stress, Psychological | 1 | 2017 | 4538 | 0.010 |
Why?
|
| Neoplasm Metastasis | 2 | 1989 | 4931 | 0.010 |
Why?
|
| Lung Volume Measurements | 1 | 2002 | 383 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 20232 | 0.010 |
Why?
|
| Plethysmography | 1 | 2000 | 174 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 7467 | 0.010 |
Why?
|
| Cells, Cultured | 3 | 1990 | 19035 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 2002 | 962 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2012 | 3076 | 0.010 |
Why?
|
| Prognosis | 1 | 2020 | 30031 | 0.010 |
Why?
|
| Airway Resistance | 1 | 2000 | 406 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2012 | 9558 | 0.010 |
Why?
|
| Case Management | 1 | 2000 | 276 | 0.010 |
Why?
|
| Maximal Voluntary Ventilation | 1 | 1998 | 14 | 0.010 |
Why?
|
| Patient Selection | 1 | 2010 | 4266 | 0.010 |
Why?
|
| Smoking | 1 | 1995 | 9099 | 0.010 |
Why?
|
| Heart Failure | 1 | 2002 | 11859 | 0.010 |
Why?
|
| Hyperventilation | 1 | 1998 | 78 | 0.010 |
Why?
|
| Sputum | 1 | 2000 | 511 | 0.010 |
Why?
|
| Animals | 5 | 2014 | 169424 | 0.010 |
Why?
|
| Total Lung Capacity | 1 | 1998 | 149 | 0.010 |
Why?
|
| Phenotype | 3 | 1990 | 16712 | 0.010 |
Why?
|
| Administration, Inhalation | 1 | 2000 | 1170 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 3 | 1992 | 22365 | 0.010 |
Why?
|
| Bronchoconstriction | 1 | 1998 | 141 | 0.010 |
Why?
|
| Mice | 4 | 2012 | 82051 | 0.010 |
Why?
|
| Cell Count | 1 | 2000 | 1834 | 0.010 |
Why?
|
| Survival Rate | 1 | 2010 | 12875 | 0.010 |
Why?
|
| Eosinophils | 1 | 2000 | 955 | 0.010 |
Why?
|
| Recombinant Proteins | 3 | 1990 | 6527 | 0.010 |
Why?
|
| Young Adult | 1 | 2021 | 60038 | 0.010 |
Why?
|
| ROC Curve | 1 | 2002 | 3623 | 0.010 |
Why?
|
| Cold Temperature | 1 | 1998 | 786 | 0.010 |
Why?
|
| Survival Analysis | 2 | 2000 | 10127 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 2002 | 1949 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 1998 | 1152 | 0.010 |
Why?
|
| Health Services Research | 1 | 2000 | 1815 | 0.010 |
Why?
|
| Steroids | 1 | 1998 | 937 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 65408 | 0.010 |
Why?
|
| Algorithms | 1 | 2013 | 14157 | 0.010 |
Why?
|
| Risk Factors | 1 | 2018 | 74915 | 0.010 |
Why?
|
| Allergens | 1 | 1998 | 1445 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1992 | 1629 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1998 | 6242 | 0.010 |
Why?
|
| Lung Neoplasms | 2 | 1992 | 13589 | 0.000 |
Why?
|
| Hypersensitivity | 1 | 1998 | 1172 | 0.000 |
Why?
|
| Odds Ratio | 1 | 2000 | 9687 | 0.000 |
Why?
|
| Drug Tolerance | 1 | 1990 | 367 | 0.000 |
Why?
|
| Neoplasm Transplantation | 1 | 1992 | 2017 | 0.000 |
Why?
|
| Boston | 1 | 2000 | 9359 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 14725 | 0.000 |
Why?
|
| Proportional Hazards Models | 1 | 2000 | 12561 | 0.000 |
Why?
|
| Logistic Models | 1 | 2000 | 13323 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2002 | 15459 | 0.000 |
Why?
|
| Prevalence | 1 | 2002 | 15879 | 0.000 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1989 | 1852 | 0.000 |
Why?
|
| Lymphocytes | 1 | 1989 | 2611 | 0.000 |
Why?
|
| Combined Modality Therapy | 1 | 1992 | 8559 | 0.000 |
Why?
|
| Immunotherapy | 1 | 1990 | 4728 | 0.000 |
Why?
|